- Home
- VHC vs CRIS Comparison
VHC vs CRIS Comparison
Compare VHC & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VHC
- CRIS
- Stock Information
- Founded
- VHC 2005
- CRIS 2000
- Country
- VHC United States
- CRIS United States
- Employees
- VHC N/A
- CRIS N/A
- Industry
- VHC Multi-Sector Companies
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VHC Miscellaneous
- CRIS Health Care
- Exchange
- VHC Nasdaq
- CRIS Nasdaq
- Market Cap
- VHC 26.2M
- CRIS 31.2M
- IPO Year
- VHC 1999
- CRIS 2000
- Fundamental
- Price
- VHC $3.87
- CRIS $3.22
- Analyst Decision
- VHC
- CRIS Strong Buy
- Analyst Count
- VHC 0
- CRIS 3
- Target Price
- VHC N/A
- CRIS $23.00
- AVG Volume (30 Days)
- VHC 12.2K
- CRIS 67.7K
- Earning Date
- VHC 11-13-2024
- CRIS 02-06-2025
- Dividend Yield
- VHC N/A
- CRIS N/A
- EPS Growth
- VHC N/A
- CRIS N/A
- EPS
- VHC N/A
- CRIS N/A
- Revenue
- VHC $5,000.00
- CRIS $10,259,000.00
- Revenue This Year
- VHC N/A
- CRIS N/A
- Revenue Next Year
- VHC N/A
- CRIS N/A
- P/E Ratio
- VHC N/A
- CRIS N/A
- Revenue Growth
- VHC N/A
- CRIS 0.44
- 52 Week Low
- VHC $3.55
- CRIS $3.22
- 52 Week High
- VHC $9.44
- CRIS $17.49
- Technical
- Relative Strength Index (RSI)
- VHC 18.59
- CRIS 29.11
- Support Level
- VHC $4.39
- CRIS $3.75
- Resistance Level
- VHC $5.19
- CRIS $4.25
- Average True Range (ATR)
- VHC 0.31
- CRIS 0.33
- MACD
- VHC -0.07
- CRIS -0.06
- Stochastic Oscillator
- VHC 1.17
- CRIS 0.00
About VHC VirnetX Holding Corp
VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services, and critical infrastructures.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.